Exhibit 99.3
NUTRIEN LTD.
INTERIM FINANCIAL STATEMENTS AND NOTES
AS AT AND FOR THE THREE AND NINE MONTHS ENDED
SEPTEMBER 30, 2020
Unaudited | In millions of US dollars except as otherwise noted |
Condensed Consolidated Financial Statements
Condensed Consolidated Statements of (Loss) Earnings
Three Months Ended September 30 | Nine Months Ended September 30 | |||||||||||||||||
Note | 2020 | 2019 | 2020 | 2019 | ||||||||||||||
Note 1 | Note 1 | |||||||||||||||||
SALES | 2 | 4,205 | 4,169 | 16,807 | 16,581 | |||||||||||||
Freight, transportation and distribution | 204 | 210 | 653 | 596 | ||||||||||||||
Cost of goods sold | 3,004 | 2,819 | 12,129 | 11,558 | ||||||||||||||
GROSS MARGIN | 997 | 1,140 | 4,025 | 4,427 | ||||||||||||||
Selling expenses | 676 | 607 | 2,081 | 1,835 | ||||||||||||||
General and administrative expenses | 107 | 97 | 312 | 287 | ||||||||||||||
Provincial mining and other taxes | 58 | 92 | 163 | 253 | ||||||||||||||
Share-based compensation expense (recovery) | 29 | (21 | ) | 9 | 95 | |||||||||||||
Impairment of assets | 3 | 823 | - | 823 | 33 | |||||||||||||
Other expenses | 4 | 26 | 37 | 138 | 125 | |||||||||||||
(LOSS) EARNINGS BEFORE FINANCE COSTS AND INCOME TAXES | (722 | ) | 328 | 499 | 1,799 | |||||||||||||
Finance costs | 129 | 147 | 401 | 413 | ||||||||||||||
(LOSS) EARNINGS BEFORE INCOME TAXES | (851 | ) | 181 | 98 | 1,386 | |||||||||||||
Income tax (recovery) expense | 5 | (264 | ) | 40 | (45 | ) | 346 | |||||||||||
NET (LOSS) EARNINGS | (587 | ) | 141 | 143 | 1,040 | |||||||||||||
NET (LOSS) EARNINGS PER SHARE (“EPS”) | ||||||||||||||||||
Basic | (1.03 | ) | 0.25 | 0.25 | 1.78 | |||||||||||||
Diluted | (1.03 | ) | 0.24 | 0.25 | 1.77 | |||||||||||||
Weighted average shares outstanding for basic EPS | 569,146,000 | 572,887,000 | 569,818,000 | 585,421,000 | ||||||||||||||
Weighted average shares outstanding for diluted EPS | 569,146,000 | 573,702,000 | 569,818,000 | 586,335,000 |
Condensed Consolidated Statements of Comprehensive (Loss) Income
Three Months Ended September 30 | Nine Months Ended September 30 | |||||||||||||||
(Net of related income taxes) | 2020 | 2019 | 2020 | 2019 | ||||||||||||
NET (LOSS) EARNINGS | (587 | ) | 141 | 143 | 1,040 | |||||||||||
Other comprehensive income (loss) | ||||||||||||||||
Items that will not be reclassified to net (loss) earnings: | ||||||||||||||||
Net actuarial gain on defined benefit plans | - | - | 3 | - | ||||||||||||
Net fair value loss on investments | (4 | ) | (11 | ) | (25 | ) | (26 | ) | ||||||||
Items that have been or may be subsequently reclassified to net (loss) earnings: | ||||||||||||||||
Gain (loss) on currency translation of foreign operations | 69 | (71 | ) | (52 | ) | (36 | ) | |||||||||
Other | 6 | 7 | (12 | ) | 5 | |||||||||||
OTHER COMPREHENSIVE INCOME (LOSS) | 71 | (75 | ) | (86 | ) | (57 | ) | |||||||||
COMPREHENSIVE (LOSS) INCOME | (516 | ) | 66 | 57 | 983 |
(See Notes to the Condensed Consolidated Financial Statements)
24
Unaudited | In millions of US dollars except as otherwise noted |
Condensed Consolidated Statements of Cash Flows
Three Months Ended September 30 | Nine Months Ended September 30 | |||||||||||||||||||
Note | 2020 | 2019 | 2020 | 2019 | ||||||||||||||||
Note 1 | Note 1 | |||||||||||||||||||
OPERATING ACTIVITIES | ||||||||||||||||||||
Net (loss) earnings | (587 | ) | 141 | 143 | 1,040 | |||||||||||||||
Adjustments for: | ||||||||||||||||||||
Depreciation and amortization | 500 | 457 | 1,490 | 1,363 | ||||||||||||||||
Share-based compensation expense (recovery) | 29 | (21 | ) | 9 | 95 | |||||||||||||||
Impairment of assets | 3 | 823 | - | 823 | 33 | |||||||||||||||
(Recovery of) provision for deferred income tax | (161 | ) | 31 | (99 | ) | 178 | ||||||||||||||
Other long-term liabilities and miscellaneous | (121 | ) | (23 | ) | (221 | ) | (23 | ) | ||||||||||||
Cash from operations before working capital changes | 483 | 585 | 2,145 | 2,686 | ||||||||||||||||
Changes in non-cash operating working capital: | ||||||||||||||||||||
Receivables | 692 | 624 | (1,455 | ) | (1,427 | ) | ||||||||||||||
Inventories | 407 | 541 | 1,153 | 1,239 | ||||||||||||||||
Prepaid expenses and other current assets | (77 | ) | (23 | ) | 936 | 801 | ||||||||||||||
Payables and accrued charges | (2,190 | ) | (1,138 | ) | (2,234 | ) | (2,053 | ) | ||||||||||||
CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES | (685 | ) | 589 | 545 | 1,246 | |||||||||||||||
INVESTING ACTIVITIES | ||||||||||||||||||||
Additions to property, plant and equipment | (266 | ) | (518 | ) | (927 | ) | (1,177 | ) | ||||||||||||
Additions to intangible assets | (19 | ) | (43 | ) | (87 | ) | (118 | ) | ||||||||||||
Business acquisitions, net of cash acquired | 10 | (43 | ) | (348 | ) | (216 | ) | (837 | ) | |||||||||||
Proceeds from disposal of discontinued operations, net of tax | - | - | - | 55 | ||||||||||||||||
Purchase of investments | (13 | ) | (42 | ) | (79 | ) | (164 | ) | ||||||||||||
Other | (15 | ) | 47 | 100 | 108 | |||||||||||||||
CASH USED IN INVESTING ACTIVITIES | (356 | ) | (904 | ) | (1,209 | ) | (2,133 | ) | ||||||||||||
FINANCING ACTIVITIES | ||||||||||||||||||||
Transaction costs on long-term debt | - | - | (15 | ) | (29 | ) | ||||||||||||||
Proceeds from short-term debt, net | 397 | 575 | 601 | 1,534 | ||||||||||||||||
Proceeds from long-term debt | 8 | 14 | - | 1,520 | 1,510 | |||||||||||||||
Repayment of long-term debt | 8 | - | (11 | ) | (507 | ) | (1,010 | ) | ||||||||||||
Repayment of principal portion of lease liabilities | (69 | ) | (49 | ) | (203 | ) | (166 | ) | ||||||||||||
Dividends paid | 9 | (257 | ) | (244 | ) | (771 | ) | (764 | ) | |||||||||||
Repurchase of common shares | 9 | - | - | (160 | ) | (1,930 | ) | |||||||||||||
Issuance of common shares | - | 1 | - | 18 | ||||||||||||||||
CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES | 85 | 272 | 465 | (837 | ) | |||||||||||||||
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS | 6 | (5 | ) | (7 | ) | (22 | ) | |||||||||||||
DECREASE IN CASH AND CASH EQUIVALENTS |
| (950 | ) | (48 | ) | (206 | ) | (1,746 | ) | |||||||||||
CASH AND CASH EQUIVALENTS – BEGINNING OF PERIOD | 1,415 | 616 | 671 | 2,314 | ||||||||||||||||
CASH AND CASH EQUIVALENTS – END OF PERIOD | 465 | 568 | 465 | 568 | ||||||||||||||||
Cash and cash equivalents comprised of: | ||||||||||||||||||||
Cash | 328 | 326 | 328 | 326 | ||||||||||||||||
Short-term investments | 137 | 242 | 137 | 242 | ||||||||||||||||
465 | 568 | 465 | 568 | |||||||||||||||||
SUPPLEMENTAL CASH FLOWS INFORMATION | ||||||||||||||||||||
Interest paid | 85 | 111 | 334 | 353 | ||||||||||||||||
Income taxes paid | 27 | 46 | 92 | 1 | ||||||||||||||||
Total cash outflow for leases | 78 | 89 | 266 | 253 |
(See Notes to the Condensed Consolidated Financial Statements)
25
Unaudited | In millions of US dollars except as otherwise noted |
Condensed Consolidated Statements of Changes in Shareholders’ Equity
Accumulated Other Comprehensive (Loss) Income (“AOCI”) | ||||||||||||||||||||||||||||||||||||||||
Number of Common Shares | Share Capital | Contributed Surplus | Net Fair Value Loss on Investments | Net Actuarial Gain on Defined Benefit Plans 1 | Loss on Currency Translation of Foreign Operations | Other | Total AOCI | Retained Earnings | Total Equity 2 | |||||||||||||||||||||||||||||||
BALANCE – DECEMBER 31, 2018 | 608,535,477 | 16,740 | 231 | (7 | ) | - | (251 | ) | (33 | ) | (291 | ) | 7,745 | 24,425 | ||||||||||||||||||||||||||
Net earnings | - | - | - | - | - | - | - | - | 1,040 | 1,040 | ||||||||||||||||||||||||||||||
Other comprehensive (loss) income | - | - | - | (26 | ) | - | (36 | ) | 5 | (57 | ) | - | (57 | ) | ||||||||||||||||||||||||||
Shares repurchased (Note 9) | (36,066,766 | ) | (992 | ) | - | - | - | - | - | - | (886 | ) | (1,878 | ) | ||||||||||||||||||||||||||
Dividends declared | - | - | - | - | - | - | - | - | (496 | ) | (496 | ) | ||||||||||||||||||||||||||||
Effect of share-based compensation including issuance of common shares | 431,485 | 21 | 13 | - | - | - | - | - | - | 34 | ||||||||||||||||||||||||||||||
Transfer of net loss on sale of investment | - | - | - | 4 | - | - | - | 4 | (4 | ) | - | |||||||||||||||||||||||||||||
Transfer of net loss on cash flow hedges | - | - | - | - | - | - | 8 | 8 | - | 8 | ||||||||||||||||||||||||||||||
BALANCE – SEPTEMBER 30, 2019 | 572,900,196 | 15,769 | 244 | (29 | ) | - | (287 | ) | (20 | ) | (336 | ) | 7,399 | 23,076 | ||||||||||||||||||||||||||
BALANCE – DECEMBER 31, 2019 | 572,942,809 | 15,771 | 248 | (29 | ) | - | (204 | ) | (18 | ) | (251 | ) | 7,101 | 22,869 | ||||||||||||||||||||||||||
Net earnings | - | - | - | - | - | - | - | - | 143 | 143 | ||||||||||||||||||||||||||||||
Other comprehensive (loss) income | - | - | - | (25 | ) | 3 | (52 | ) | (12 | ) | (86 | ) | - | (86 | ) | |||||||||||||||||||||||||
Shares repurchased (Note 9) | (3,832,580 | ) | (105 | ) | (55 | ) | - | - | - | - | - | - | (160 | ) | ||||||||||||||||||||||||||
Dividends declared | - | - | - | - | - | - | - | - | (770 | ) | (770 | ) | ||||||||||||||||||||||||||||
Effect of share-based compensation including issuance of common shares | 35,706 | 1 | 10 | - | - | - | - | - | - | 11 | ||||||||||||||||||||||||||||||
Transfer of net loss on cash flow hedges | - | - | - | - | - | - | 13 | 13 | - | 13 | ||||||||||||||||||||||||||||||
Transfer of net actuarial gain on defined benefit plans | - | - | - | - | (3 | ) | - | - | (3 | ) | 3 | - | ||||||||||||||||||||||||||||
BALANCE – SEPTEMBER 30, 2020 | 569,145,935 | 15,667 | 203 | (54 | ) | - | (256 | ) | (17 | ) | (327 | ) | 6,477 | 22,020 |
1 Any amounts incurred during a period were transferred to retained earnings at each period-end. Therefore, no balance exists at the beginning or end of period.
2 All equity transactions were attributable to common shareholders.
(See Notes to the Condensed Consolidated Financial Statements)
26
Unaudited | In millions of US dollars except as otherwise noted |
Condensed Consolidated Balance Sheets
September 30 | December 31 | |||||||||||||||||||
As at | Note | 2020 | 2019 | 2019 | ||||||||||||||||
ASSETS | ||||||||||||||||||||
Current assets | ||||||||||||||||||||
Cash and cash equivalents | 465 | 568 | 671 | |||||||||||||||||
Receivables | 5,056 | 4,843 | 3,542 | |||||||||||||||||
Inventories | 3,829 | 3,873 | 4,975 | |||||||||||||||||
Prepaid expenses and other current assets | 531 | 440 | 1,477 | |||||||||||||||||
9,881 | 9,724 | 10,665 | ||||||||||||||||||
Non-current assets | ||||||||||||||||||||
Property, plant and equipment | 3 | 19,308 | 20,045 | 20,335 | ||||||||||||||||
Goodwill | 10 | 12,179 | 11,983 | 11,986 | ||||||||||||||||
Other intangible assets | 2,352 | 2,330 | 2,428 | |||||||||||||||||
Investments | 809 | 809 | 821 | |||||||||||||||||
Other assets | 742 | 538 | 564 | |||||||||||||||||
TOTAL ASSETS | 45,271 | 45,429 | 46,799 | |||||||||||||||||
LIABILITIES | ||||||||||||||||||||
Current liabilities | ||||||||||||||||||||
Short-term debt | 7 | 1,644 | 2,287 | 976 | ||||||||||||||||
Current portion of long-term debt | 8 | - | 501 | 502 | ||||||||||||||||
Current portion of lease liabilities | 230 | 219 | 214 | |||||||||||||||||
Payables and accrued charges | 5,239 | 4,615 | 7,437 | |||||||||||||||||
7,113 | 7,622 | 9,129 | ||||||||||||||||||
Non-current liabilities | ||||||||||||||||||||
Long-term debt | 8 | 10,041 | 8,555 | 8,553 | ||||||||||||||||
Lease liabilities | 847 | 793 | 859 | |||||||||||||||||
Deferred income tax liabilities | 5 | 3,053 | 3,137 | 3,145 | ||||||||||||||||
Pension and other post-retirement benefit liabilities | 446 | 425 | 433 | |||||||||||||||||
Asset retirement obligations and accrued environmental costs | 1,575 | 1,662 | 1,650 | |||||||||||||||||
Other non-current liabilities | 176 | 159 | 161 | |||||||||||||||||
TOTAL LIABILITIES | 23,251 | 22,353 | 23,930 | |||||||||||||||||
SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
Share capital | 9 | 15,667 | 15,769 | 15,771 | ||||||||||||||||
Contributed surplus | 203 | 244 | 248 | |||||||||||||||||
Accumulated other comprehensive loss | (327 | ) | (336 | ) | (251 | ) | ||||||||||||||
Retained earnings | 6,477 | 7,399 | 7,101 | |||||||||||||||||
TOTAL SHAREHOLDERS’ EQUITY | 22,020 | 23,076 | 22,869 | |||||||||||||||||
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | 45,271 | 45,429 | 46,799 |
(See Notes to the Condensed Consolidated Financial Statements)
27
Unaudited | In millions of US dollars except as otherwise noted |
Notes to the Condensed Consolidated Financial Statements
As at and for the Three and Nine Months Ended September 30, 2020
NOTE 1 BASIS OF PRESENTATION
Nutrien Ltd. (collectively with its subsidiaries, known as “Nutrien”, “we”, “us”, “our” or the “Company”) is the world’s largest provider of crop inputs and services. Nutrien plays a critical role in helping growers around the globe increase food production in a sustainable manner.
These unaudited interim condensed consolidated financial statements (“interim financial statements”) are based on International Financial Reporting Standards as issued by the International Accounting Standards Board (“IFRS”) and have been prepared in accordance with International Accounting Standard 34, “Interim Financial Reporting”. The accounting policies and methods of computation used in preparing these interim financial statements are consistent with those used in the preparation of our 2019 annual consolidated financial statements. These interim financial statements include the accounts of Nutrien and its subsidiaries; however, they do not include all disclosures normally provided in annual consolidated financial statements and should be read in conjunction with our 2019 annual consolidated financial statements.
Certain immaterial 2019 figures have been reclassified in the condensed consolidated statements of (loss) earnings, condensed consolidated statements of cash flows and segment information.
In management’s opinion, the interim financial statements include all adjustments necessary to fairly present such information in all material respects. Interim results are not necessarily indicative of the results expected for any other interim period or the fiscal year. On March 11, 2020, the World Health Organization declared the novel strain of coronavirus (“COVID-19”) a global pandemic. We have assessed our accounting estimates and other matters that require the use of forecasted financial information for the impact of the COVID-19 pandemic. The assessment included estimates of the unknown future impacts of the pandemic using information that is reasonably available at this time. Accounting estimates and other matters assessed include the allowance for expected credit losses of receivables from customers, inventory valuation, goodwill and other long-lived assets, financial assets, tax assets, pension obligation and assets, and revenue recognition. Based on our current assessment, there was not a material impact to these interim financial statements. As additional information becomes available, the future assessment of these estimates, including expectations about the severity, duration and scope of the pandemic, could differ materially in future reporting periods.
These interim financial statements were authorized by the audit committee of the Board of Directors for issue on November 2, 2020.
NOTE 2 SEGMENT INFORMATION
The Company has four reportable operating segments: Retail, Potash, Nitrogen and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seed and merchandise, and provides services directly to growers through a network of farm centers in North America, South America and Australia. The Potash, Nitrogen and Phosphate segments are differentiated by the chemical nutrient contained in the products that each produces. Sales reported under our Corporate and Others segment primarily relates to our non-core Canadian business which was sold in the third quarter of 2020.
In the third quarter of 2020, our Chief Operating Decision Maker changed the measure used to evaluate the performance of our operating segments from net earnings (loss) before finance costs, income taxes, and depreciation and amortization (“EBITDA”) to adjusted EBITDA. Adjusted EBITDA provides a better indication of the segments performance as it excludes the impact of impairments and other costs that are centrally managed by our corporate function. Due to the change in the measurement of the segments, we have presented adjusted EBITDA for the comparative periods.
28
Unaudited | In millions of US dollars except as otherwise noted |
Three Months Ended September 30, 2020 | ||||||||||||||||||||||||||||
Retail | Potash | Nitrogen | Phosphate | Corporate and Others | Eliminations | Consolidated | ||||||||||||||||||||||
Sales – third party | 2,712 | 634 | 524 | 312 | 23 | - | 4,205 | |||||||||||||||||||||
– intersegment | 8 | 63 | 103 | 40 | - | (214 | ) | - | ||||||||||||||||||||
Sales – total | 2,720 | 697 | 627 | 352 | 23 | (214 | ) | 4,205 | ||||||||||||||||||||
Freight, transportation and distribution | - | 106 | 87 | 60 | - | (49 | ) | 204 | ||||||||||||||||||||
Net sales | 2,720 | 591 | 540 | 292 | 23 | (165 | ) | 4,001 | ||||||||||||||||||||
Cost of goods sold | 2,059 | 303 | 482 | 293 | 20 | (153 | ) | 3,004 | ||||||||||||||||||||
Gross margin | 661 | 288 | 58 | (1 | ) | 3 | (12 | ) | 997 | |||||||||||||||||||
Selling expenses | 669 | 3 | 7 | 1 | (4 | ) | - | 676 | ||||||||||||||||||||
General and administrative expenses | 34 | 2 | 3 | 2 | 66 | - | 107 | |||||||||||||||||||||
Provincial mining and other taxes | - | 58 | - | - | - | - | 58 | |||||||||||||||||||||
Share-based compensation expense | - | - | - | - | 29 | - | 29 | |||||||||||||||||||||
Impairment of assets | - | 22 | 27 | 769 | 5 | - | 823 | |||||||||||||||||||||
Other (income) expenses | (34 | ) | (1 | ) | (16 | ) | 10 | 67 | - | 26 | ||||||||||||||||||
(Loss) earnings before finance costs and income taxes | (8 | ) | 204 | 37 | (783 | ) | (160 | ) | (12 | ) | (722 | ) | ||||||||||||||||
Depreciation and amortization | 170 | 124 | 131 | 60 | 15 | - | 500 | |||||||||||||||||||||
EBITDA | 162 | 328 | 168 | (723 | ) | (145 | ) | (12 | ) | (222 | ) | |||||||||||||||||
Acquisition and integration related costs | - | - | - | - | 10 | - | 10 | |||||||||||||||||||||
Share-based compensation expense | - | - | - | - | 29 | - | 29 | |||||||||||||||||||||
Impairment of assets | - | 22 | 27 | 769 | 5 | - | 823 | |||||||||||||||||||||
COVID-19 related expenses | - | - | - | - | 11 | - | 11 | |||||||||||||||||||||
Foreign exchange loss, net of related derivatives | - | - | - | - | 13 | - | 13 | |||||||||||||||||||||
Loss on disposal of business | - | - | - | - | 6 | - | 6 | |||||||||||||||||||||
Adjusted EBITDA | 162 | 350 | 195 | 46 | (71 | ) | (12 | ) | 670 | |||||||||||||||||||
Assets – at September 30, 2020 | 19,722 | 12,005 | 10,805 | 1,362 | 1,760 | (383 | ) | 45,271 | ||||||||||||||||||||
Three Months Ended September 30, 2019 | ||||||||||||||||||||||||||||
Retail | Potash | Nitrogen | Phosphate | Corporate and Others | Eliminations | Consolidated | ||||||||||||||||||||||
Sales – third party | 2,489 | 748 | 564 | 333 | 35 | - | 4,169 | |||||||||||||||||||||
– intersegment | 10 | 68 | 115 | 43 | - | (236 | ) | - | ||||||||||||||||||||
Sales – total | 2,499 | 816 | 679 | 376 | 35 | (236 | ) | 4,169 | ||||||||||||||||||||
Freight, transportation and distribution | - | 107 | 77 | 62 | - | (36 | ) | 210 | ||||||||||||||||||||
Net sales | 2,499 | 709 | 602 | 314 | 35 | (200 | ) | 3,959 | ||||||||||||||||||||
Cost of goods sold | 1,844 | 303 | 469 | 329 | 35 | (161 | ) | 2,819 | ||||||||||||||||||||
Gross margin | 655 | 406 | 133 | (15 | ) | - | (39 | ) | 1,140 | |||||||||||||||||||
Selling expenses | 601 | 2 | 7 | 2 | (5 | ) | - | 607 | ||||||||||||||||||||
General and administrative expenses | 28 | - | 4 | - | 65 | - | 97 | |||||||||||||||||||||
Provincial mining and other taxes | - | 83 | 1 | - | 8 | - | 92 | |||||||||||||||||||||
Share-based compensation recovery | - | - | - | - | (21 | ) | - | (21 | ) | |||||||||||||||||||
Other (income) expenses | (12 | ) | 1 | 1 | 7 | 40 | - | 37 | ||||||||||||||||||||
Earnings (loss) before finance costs and income taxes | 38 | 320 | 120 | (24 | ) | (87 | ) | (39 | ) | 328 | ||||||||||||||||||
Depreciation and amortization | 152 | 110 | 127 | 58 | 10 | - | 457 | |||||||||||||||||||||
EBITDA | 190 | 430 | 247 | 34 | (77 | ) | (39 | ) | 785 | |||||||||||||||||||
Merger and related costs | - | - | - | - | 21 | - | 21 | |||||||||||||||||||||
Share-based compensation recovery | - | - | - | - | (21 | ) | - | (21 | ) | |||||||||||||||||||
Foreign exchange loss, net of related derivatives | - | - | - | - | 2 | - | 2 | |||||||||||||||||||||
Adjusted EBITDA | 190 | 430 | 247 | 34 | (75 | ) | (39 | ) | 787 | |||||||||||||||||||
Assets – at December 31, 2019 | 19,990 | 11,696 | 10,991 | 2,198 | 2,129 | (205 | ) | 46,799 |
29
Unaudited | In millions of US dollars except as otherwise noted |
Nine Months Ended September 30, 2020 | ||||||||||||||||||||||||||||
Retail | Potash | Nitrogen | Phosphate | Corporate and Others | Eliminations | Consolidated | ||||||||||||||||||||||
Sales – third party | 12,091 | 1,798 | 1,925 | 923 | 70 | - | 16,807 | |||||||||||||||||||||
– intersegment | 27 | 191 | 481 | 146 | - | (845 | ) | - | ||||||||||||||||||||
Sales – total | 12,118 | 1,989 | 2,406 | 1,069 | 70 | (845 | ) | 16,807 | ||||||||||||||||||||
Freight, transportation and distribution | - | 293 | 335 | 187 | - | (162 | ) | 653 | ||||||||||||||||||||
Net sales | 12,118 | 1,696 | 2,071 | 882 | 70 | (683 | ) | 16,154 | ||||||||||||||||||||
Cost of goods sold | 9,316 | 878 | 1,708 | 862 | 63 | (698 | ) | 12,129 | ||||||||||||||||||||
Gross margin | 2,802 | 818 | 363 | 20 | 7 | 15 | 4,025 | |||||||||||||||||||||
Selling expenses | 2,068 | 7 | 19 | 4 | (17 | ) | - | 2,081 | ||||||||||||||||||||
General and administrative expenses | 102 | 5 | 7 | 7 | 191 | - | 312 | |||||||||||||||||||||
Provincial mining and other taxes | - | 161 | 1 | - | 1 | - | 163 | |||||||||||||||||||||
Share-based compensation expense | - | - | - | - | 9 | - | 9 | |||||||||||||||||||||
Impairment of assets | - | 22 | 27 | 769 | 5 | - | 823 | |||||||||||||||||||||
Other (income) expenses | (13 | ) | 4 | (25 | ) | 19 | 153 | - | 138 | |||||||||||||||||||
Earnings (loss) before finance costs and income taxes | 645 | 619 | 334 | (779 | ) | (335 | ) | 15 | 499 | |||||||||||||||||||
Depreciation and amortization | 488 | 329 | 453 | 179 | 41 | - | 1,490 | |||||||||||||||||||||
EBITDA | 1,133 | 948 | 787 | (600 | ) | (294 | ) | 15 | 1,989 | |||||||||||||||||||
Acquisition and integration related costs | - | - | - | - | 38 | - | 38 | |||||||||||||||||||||
Share-based compensation expense | - | - | - | - | 9 | - | 9 | |||||||||||||||||||||
Impairment of assets | - | 22 | 27 | 769 | 5 | - | 823 | |||||||||||||||||||||
COVID-19 related expenses | - | - | - | - | 30 | - | 30 | |||||||||||||||||||||
Foreign exchange loss, net of related derivatives | - | - | - | - | 4 | - | 4 | |||||||||||||||||||||
Loss on disposal of business | - | - | - | - | 6 | - | 6 | |||||||||||||||||||||
Adjusted EBITDA | 1,133 | 970 | 814 | 169 | (202 | ) | 15 | 2,899 | ||||||||||||||||||||
Assets – at September 30, 2020 | 19,722 | 12,005 | 10,805 | 1,362 | 1,760 | (383 | ) | 45,271 | ||||||||||||||||||||
Nine Months Ended September 30, 2019 | ||||||||||||||||||||||||||||
Retail | Potash | Nitrogen | Phosphate | Corporate and Others | Eliminations | Consolidated | ||||||||||||||||||||||
Sales – third party | 11,022 | 2,328 | 2,033 | 1,099 | 99 | - | 16,581 | |||||||||||||||||||||
– intersegment | 28 | 178 | 487 | 160 | - | (853 | ) | - | ||||||||||||||||||||
Sales – total | 11,050 | 2,506 | 2,520 | 1,259 | 99 | (853 | ) | 16,581 | ||||||||||||||||||||
Freight, transportation and distribution | - | 252 | 275 | 178 | - | (109 | ) | 596 | ||||||||||||||||||||
Net sales | 11,050 | 2,254 | 2,245 | 1,081 | 99 | (744 | ) | 15,985 | ||||||||||||||||||||
Cost of goods sold | 8,546 | 892 | 1,652 | 1,092 | 99 | (723 | ) | 11,558 | ||||||||||||||||||||
Gross margin | 2,504 | 1,362 | 593 | (11 | ) | - | (21 | ) | 4,427 | |||||||||||||||||||
Selling expenses | 1,816 | 7 | 21 | 5 | (14 | ) | - | 1,835 | ||||||||||||||||||||
General and administrative expenses | 82 | - | 11 | 3 | 191 | - | 287 | |||||||||||||||||||||
Provincial mining and other taxes | - | 237 | 2 | 1 | 13 | - | 253 | |||||||||||||||||||||
Share-based compensation expense | - | - | - | - | 95 | - | 95 | |||||||||||||||||||||
Impairment of assets | - | - | - | - | 33 | - | 33 | |||||||||||||||||||||
Other expenses (income) | 39 | (2 | ) | (27 | ) | 20 | 95 | - | 125 | |||||||||||||||||||
Earnings (loss) before finance costs and income taxes | 567 | 1,120 | 586 | (40 | ) | (413 | ) | (21 | ) | 1,799 | ||||||||||||||||||
Depreciation and amortization | 433 | 324 | 394 | 180 | 32 | - | 1,363 | |||||||||||||||||||||
EBITDA | 1,000 | 1,444 | 980 | 140 | (381 | ) | (21 | ) | 3,162 | |||||||||||||||||||
Merger and related costs | - | - | - | - | 57 | - | 57 | |||||||||||||||||||||
Share-based compensation expense | - | - | - | - | 95 | - | 95 | |||||||||||||||||||||
Impairment of assets | - | - | - | - | 33 | - | 33 | |||||||||||||||||||||
Foreign exchange loss, net of related derivatives | - | - | - | - | 14 | - | 14 | |||||||||||||||||||||
Adjusted EBITDA | 1,000 | 1,444 | 980 | 140 | (182 | ) | (21 | ) | 3,361 | |||||||||||||||||||
Assets – at December 31, 2019 | 19,990 | 11,696 | 10,991 | 2,198 | 2,129 | (205 | ) | 46,799 |
30
Unaudited | In millions of US dollars except as otherwise noted |
Presented below is revenue from contracts with customers disaggregated by product line or geographic location for each reportable segment to show how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.
Three Months Ended September 30 | Nine Months Ended September 30 | |||||||||||||||
2020 | 2019 | 2020 | 2019 | |||||||||||||
Retail sales by product line | ||||||||||||||||
Crop nutrients | 780 | 769 | 4,092 | 4,082 | ||||||||||||
Crop protection products | 1,328 | 1,318 | 4,774 | 4,348 | ||||||||||||
Seed | 103 | 60 | 1,638 | 1,613 | ||||||||||||
Merchandise | 234 | 135 | 703 | 387 | ||||||||||||
Services and other | 275 | 217 | 911 | 620 | ||||||||||||
2,720 | 2,499 | 12,118 | 11,050 | |||||||||||||
Potash sales by geography | ||||||||||||||||
Manufactured product | ||||||||||||||||
North America | 358 | 437 | 1,002 | 1,084 | ||||||||||||
Offshore 1 | 339 | 379 | 987 | 1,421 | ||||||||||||
Other potash and purchased products | - | - | - | 1 | ||||||||||||
697 | 816 | 1,989 | 2,506 | |||||||||||||
Nitrogen sales by product line | ||||||||||||||||
Manufactured product | ||||||||||||||||
Ammonia | 129 | 172 | 576 | 713 | ||||||||||||
Urea | 214 | 239 | 780 | 801 | ||||||||||||
Solutions, nitrates and sulfates | 177 | 193 | 606 | 613 | ||||||||||||
Other nitrogen and purchased products | 107 | 75 | 444 | 393 | ||||||||||||
627 | 679 | 2,406 | 2,520 | |||||||||||||
Phosphate sales by product line | ||||||||||||||||
Manufactured product | ||||||||||||||||
Fertilizer | 216 | 205 | 622 | 752 | ||||||||||||
Industrial and feed | 105 | 119 | 342 | 359 | ||||||||||||
Other phosphate and purchased products | 31 | 52 | 105 | 148 | ||||||||||||
352 | 376 | 1,069 | 1,259 |
1 Relates to Canpotex Limited (“Canpotex”) (Note 12).
NOTE 3 IMPAIRMENT OF ASSETS
During the three and nine months ended September 30, 2020, we recorded the following impairments of assets in the statement of (loss) earnings relating to our property plant and equipment:
Cash-generating units (“CGUs”) | Aurora | White Springs | ||
Segment | Phosphate | |||
Impairment indicator | Lower long-term forecasted global phosphate prices | |||
Pre-tax impairment loss ($) | 545 | 215 | ||
Recoverable value ($) | 995 (post-tax) | 160 (pre-tax) | ||
Valuation technique | Fair value less costs of disposal (“FVLCD”) a Level 3 measurement | Value in use | ||
Key assumptions | ||||
End of mine life (proven and probable reserves) (year) | 2050 | 2029 | ||
Long-term growth rate (%) | 2.0 | n/a | ||
Post-tax discount rate (%) | 10.5 | 12.0 (pre-tax - 16.0) |
For our Aurora CGU, the recoverable value was based on after-tax discounted cash flows (using a five-year projection and a terminal year thereafter to the expected mine life), which incorporated assumptions an independent market participant would apply. For our White Springs CGU, the recoverable value was based on pre-tax discounted cash flows until the end of the mine life.
The recoverable value is most sensitive to the following key assumptions: our internal sales price forecasts which consider projections from an independent third-party data source, discount rates, long-term growth rates, and expected mine life. We used key assumptions that were based on historical data and estimates of future results from internal sources, external price benchmarks, mineral reserve technical reports, as well as industry and market trends.
31
Unaudited | In millions of US dollars except as otherwise noted |
The following table highlights sensitivities to the recoverable value which could result in additional impairment losses or reversals of previously recorded losses. The sensitivities have been calculated independently of changes in other key variables.
Aurora | ||||||||||||
Key Assumptions | Change in Assumption | Increase (Decrease) to Recoverable Value ($) | ||||||||||
Net selling price | ± | 10 per tonne | ± | 150 | ||||||||
Discount rate | ± | 1.0 percentage point | ± | 120 |
For our White Springs CGU, there were no reasonably possible changes in the key assumptions that would result in a substantial change in the recoverable value.
At September 30, 2020, we performed impairment testing on the Trinidad CGU, part of our Nitrogen segment, due to the indefinite closure of an ammonia plant in response to market conditions and lower long-term forecasted global ammonia prices. No impairment resulted from comparing the carrying value of the Trinidad CGU to its recoverable value determined on a FVLCD methodology. FVLCD was based on after-tax discounted cash flows (using a five-year projection and a 2.0% terminal growth rate) discounted at a post-tax rate of 12.6%.
The following table indicates the percentages by which key assumptions would need to change individually for the estimated Trinidad CGU recoverable value to be equal to the carrying value:
Key Assumptions | Change Required for Carrying Value to Equal Recoverable Value | |||
Net selling price (5-year average) | 4 percent decrease | |||
Production volumes (5-year average) | 5 percent decrease | |||
Discount rate (post-tax) | 0.9 percentage point increase |
During the nine months ended September 30, 2020, we also recorded $63 of impairment losses relating to other non-current assets.
NOTE 4 OTHER EXPENSES (INCOME)
Three Months Ended September 30 | Nine Months Ended September 30 | |||||||||||||||
2020 | 2019 | 2020 | 2019 | |||||||||||||
Merger and related costs | - | 21 | - | 57 | ||||||||||||
Acquisition and integration related costs | 10 | - | 38 | - | ||||||||||||
Foreign exchange loss, net of related derivatives | 14 | 2 | 1 | 14 | ||||||||||||
Earnings of equity-accounted investees | (23 | ) | (6 | ) | (46 | ) | (53 | ) | ||||||||
Bad debt (recovery) expense | (18 | ) | 3 | 9 | 38 | |||||||||||
COVID-19 related expenses | 11 | - | 30 | - | ||||||||||||
Loss on disposal of business | 6 | - | 6 | - | ||||||||||||
Other expenses | 26 | 17 | 100 | 69 | ||||||||||||
26 | 37 | 138 | 125 |
32
Unaudited | In millions of US dollars except as otherwise noted |
NOTE 5 INCOME TAXES
A separate estimated average annual effective income tax rate was determined for each taxing jurisdiction and applied individually to the interim period pre-tax earnings for each jurisdiction.
Three Months Ended September 30 | Nine Months Ended September 30 | |||||||||||||||
2020 | 2019 | 2020 | 2019 | |||||||||||||
Income tax (recovery) expense | (264 | ) | 40 | (45 | ) | 346 | ||||||||||
Actual effective tax rate on loss/earnings (%) | 26 | 22 | 14 | 25 | ||||||||||||
Actual effective tax rate including discrete items (%) | 31 | 22 | (47 | ) | 25 | |||||||||||
Discrete tax adjustments that impacted the tax rate | (48 | ) | 1 | (59 | ) | 5 |
Income tax balances within the condensed consolidated balance sheets were comprised of the following:
Income Tax Assets and Liabilities | Balance Sheet Location | As at September 30, 2020 | As at December 31, 2019 | |||||||
Income tax assets | ||||||||||
Current | Receivables | 50 | 104 | |||||||
Non-current | Other assets | 213 | 36 | |||||||
Deferred income tax assets | Other assets | 258 | 249 | |||||||
Total income tax assets | 521 | 389 | ||||||||
Income tax liabilities | ||||||||||
Current | Payables and accrued charges | 105 | 43 | |||||||
Non-current | Other non-current liabilities | 40 | 44 | |||||||
Deferred income tax liabilities | Deferred income tax liabilities | 3,053 | 3,145 | |||||||
Total income tax liabilities | 3,198 | 3,232 |
NOTE 6 FINANCIAL INSTRUMENTS
Fair Value
Estimated fair values for financial instruments are designed to approximate amounts for which the instruments could be exchanged in a current arm’s-length transaction between knowledgeable, willing parties. The valuation policies and procedures for financial reporting purposes are determined by our finance department. There have been no changes to our valuation methods presented in Note 12 of the 2019 annual consolidated financial statements and those valuation methods have been applied in these interim financial statements.
The following table presents our fair value hierarchy for financial instruments carried at fair value on a recurring basis or measured at amortized cost:
September 30, 2020 | December 31, 2019 | |||||||||||||||||||||||
Financial assets (liabilities) measured at | Carrying Amount | Level 1 1 | Level 2 1 | Carrying Amount | Level 1 1 | Level 2 1 | ||||||||||||||||||
Fair value on a recurring basis | ||||||||||||||||||||||||
Cash and cash equivalents | 465 | - | 465 | 671 | - | 671 | ||||||||||||||||||
Derivative instrument assets | 31 | - | 31 | 5 | - | 5 | ||||||||||||||||||
Other current financial assets - marketable securities 2 | 155 | 23 | 132 | 193 | 27 | 166 | ||||||||||||||||||
Investments at FVTOCI 3 | 135 | 135 | - | 161 | 161 | - | ||||||||||||||||||
Derivative instrument liabilities | (35 | ) | - | (35 | ) | (33 | ) | - | (33 | ) | ||||||||||||||
Amortized cost | ||||||||||||||||||||||||
Current portion of long-term debt | ||||||||||||||||||||||||
Notes and debentures | - | - | - | (494 | ) | - | (503 | ) | ||||||||||||||||
Fixed and floating rate debt | - | - | - | (8 | ) | - | (8 | ) | ||||||||||||||||
Long-term debt | ||||||||||||||||||||||||
Notes and debentures | (10,003 | ) | (7,911 | ) | (3,494 | ) | (8,528 | ) | (1,726 | ) | (7,440 | ) | ||||||||||||
Fixed and floating rate debt | (38 | ) | - | (38 | ) | (25 | ) | - | (25 | ) |
1 During the period ended September 30, 2020, there were no transfers between Level 1 and Level 2 for financial instruments measured at fair value on a recurring basis.
2 Marketable securities consist of equity and fixed income securities. We determine the fair value of equity securities based on the bid price of identical instruments in active markets. We value fixed income securities using quoted prices of instruments with similar terms and credit risk.
3 Investments at fair value through other comprehensive income (“FVTOCI”) are comprised of shares in Sinofert Holdings Ltd.
33
Unaudited | In millions of US dollars except as otherwise noted |
NOTE 7 SHORT-TERM DEBT
Short-term debt was comprised of:
Rate of Interest (%) | Total Facility Limit as at September 30, 2020 | As at September 30, 2020 | As at December 31, 2019 | |||||||||||||
Credit facilities | ||||||||||||||||
Unsecured revolving term credit facility | NIL | 4,500 | - | - | ||||||||||||
Uncommitted revolving demand facility | NIL | 500 | - | - | ||||||||||||
Other credit facilities 1 | 0.8 - 9.5 | 600 | 193 | 326 | ||||||||||||
Commercial paper | 0.2 - 0.6 | 1,451 | 650 | |||||||||||||
1,644 | 976 | |||||||||||||||
1 Other credit facilities are unsecured and consist of South American facilities with debt of $143 (December 31, 2019 – $149) and interest rates ranging from 2.0 percent to 9.5 percent, Australian facilities with debt of $24 (December 31, 2019 – $157) and an interest rate of 1.3 percent, and other facilities with debt of $26 (December 31, 2019 – $20) and interest rates ranging from 0.8 percent to 4.0 percent. |
|
The amount available under the commercial paper program is limited to the availability of backup funds under the $4,500 unsecured revolving term credit facility and excess cash invested in highly liquid securities.
During the nine months ended September 30, 2020, we entered into new committed revolving credit facilities totaling approximately $1,500, all with the same principal covenants and events of default as our existing credit facilities. We closed these credit facilities after the issuance of the new notes as described in Note 8.
NOTE 8 LONG-TERM DEBT
The following tables summarize our long-term debt issuances and repayment activities during the nine months ended September 30, 2020:
Rate of interest (%) | Maturity | Amount | ||||||||||
Notes issued 2020 | 1.900 | May 13, 2023 | 500 | |||||||||
Notes issued 2020 | 2.950 | May 13, 2030 | 500 | |||||||||
Notes issued 2020 | 3.950 | May 13, 2050 | 500 | |||||||||
1,500 |
The notes issued in 2020 are unsecured, rank equally with our existing unsecured notes, and have no sinking fund requirements prior to maturity. Each series is redeemable and provides for redemption prior to maturity, at our option, at specified prices.
Rate of interest (%) | Maturity | Amount | ||||||||||
Notes repaid 2020 | 4.875 | March 30, 2020 | 500 |
In March 2020, we filed a base shelf prospectus in Canada and the US qualifying the issuance of up to $5,000 of common shares, debt and other securities during a period of 25 months from March 16, 2020. Issuance of securities requires us to file a prospectus supplement and is subject to availability of funding in capital markets. During the nine months ended September 30, 2020, we filed a prospectus supplement to issue $1,500 of notes, as described above.
34
Unaudited | In millions of US dollars except as otherwise noted |
NOTE 9 SHARE CAPITAL
Share repurchase programs
Board of Directors Approval | Expiry | Maximum Shares for Repurchase | ||||||||||
2019 Normal Course Issuer Bid 1 | February 20, 2019 | February 26, 2020 | 42,164,420 | |||||||||
2020 Normal Course Issuer Bid 2 | February 18, 2020 | February 26, 2021 | 28,572,458 |
1 The 2019 normal course issuer bid permitted the repurchase of up to 7 percent of our outstanding common shares for cancellation. As of the expiry date, we had repurchased 33,256,668 of the maximum shares for repurchase.
2 The 2020 normal course issuer bid permits the repurchase of up to 5 percent of our outstanding common shares for cancellation and can expire earlier than the date above if we acquire the maximum number of common shares allowable or otherwise decide not to make any further repurchases.
Purchases under the normal course issuer bids were, or may be, made through open market purchases at market prices as well as by other means permitted by applicable securities regulatory authorities, including private agreements.
The following table summarizes our share repurchase activities during the period:
Three Months Ended September 30 | Nine Months Ended September 30 | |||||||||||||||
2020 | 2019 | 2020 | 2019 | |||||||||||||
Number of common shares repurchased for cancellation | - | - | 3,832,580 | 36,066,766 | ||||||||||||
Average price per share (US dollars) | - | - | 41.96 | 52.07 | ||||||||||||
Total cost | - | - | 160 | 1,878 |
Dividends declared
We declared dividends per share of $0.45 (2019 – $0.45) during the three months ended September 30, 2020, payable on October 16, 2020 to shareholders of record on September 30, 2020 and $1.35 (2019 – $0.88) during the nine months ended September 30, 2020.
NOTE 10 BUSINESS ACQUISITIONS
Ruralco
On September 30, 2019, we acquired Ruralco Holdings Limited (“Ruralco”) for a purchase price, net of cash and cash equivalents acquired, of $330. We have completed our assessment of identifying and measuring all the assets acquired and liabilities assumed. This assessment included a thorough review of all internal and external sources of information available on circumstances that existed at the acquisition date. We engaged independent valuation experts to assist in determining the fair value of certain assets acquired and liabilities assumed. The significant fair value considerations used in determining the allocation of purchase price are consistent with those disclosed in Note 4 of the 2019 annual consolidated financial statements.
Other Acquisitions
During the nine months ended September 30, 2020, we acquired several businesses, the largest of which was Tec Agro Group, a leading agriculture retailer in Brazil. The acquired businesses include 37 Retail locations in North and South America and Australia. Expected benefits of the acquisitions include expansion of geographical coverage for the sale of crop input products and services, an increased customer base and workforce, and synergies between Nutrien and the acquired businesses.
35
Unaudited | In millions of US dollars except as otherwise noted |
The fair values allocated to the acquired assets and assumed liabilities were as follows:
September 30, 2020 | ||||||||||||||||||||
Ruralco | Other Acquisitions | |||||||||||||||||||
Preliminary 1 | Adjustments | Final Fair Value | Preliminary | |||||||||||||||||
Receivables | 318 | (2 | ) | 316 | 2 | 69 | ||||||||||||||
Inventories | 115 | (3 | ) | 112 | 63 | |||||||||||||||
Prepaid expenses and other current assets | 8 | (1 | ) | 7 | 4 | |||||||||||||||
Property, plant and equipment | 136 | 4 | 140 | 53 | ||||||||||||||||
Goodwill | 207 | 29 | 236 | 184 | ||||||||||||||||
Other intangible assets | 210 | (2 | ) | 208 | - | |||||||||||||||
Investments | 15 | - | 15 | - | ||||||||||||||||
Other assets | 16 | (14 | ) | 2 | - | |||||||||||||||
Total assets | 1,025 | 11 | 1,036 | 373 | ||||||||||||||||
Short-term debt | 167 | - | 167 | 36 | ||||||||||||||||
Payables and accrued charges | 363 | (39 | ) | 324 | 111 | |||||||||||||||
Lease liabilities, including current portion | 110 | - | 110 | - | ||||||||||||||||
Deferred income tax liabilities | 42 | (11 | ) | 31 | 1 | |||||||||||||||
Other non-current liabilities | 13 | 61 | 74 | 9 | ||||||||||||||||
Total liabilities | 695 | 11 | 706 | 157 | ||||||||||||||||
Total consideration | 330 | - | 330 | 216 |
1 As previously reported in our second quarter financial statements. We recorded additional adjustments to the preliminary fair value primarily related to changes in the preliminary valuation assumptions, including refinement of our liabilities. All measurement period adjustments were offset against goodwill.
2 Includes receivables from customers with gross contractual amounts of $260, of which $7 are considered to be uncollectible.
Financial information related to business acquisitions is as follows:
Pro Forma 1 | Other Acquisitions | |||
Sales | 320 | |||
EBIT | 24 |
1 Estimated annual sales and earnings before finance costs and income taxes (“EBIT”) if acquisitions occurred at January 1, 2020.
Three Months Ended September 30, 2020 | Nine Months Ended September 30, 2020 | |||||||
From date of acquisition | Other Acquisitions | Other Acquisitions | ||||||
Sales | 60 | 100 | ||||||
EBIT | 6 | 6 |
NOTE 11 SEASONALITY
Seasonality in our business results from increased demand for products during planting season. Crop input sales are generally higher in spring and fall application seasons. Crop input inventories are normally accumulated leading up to each application season. The results of this seasonality have a corresponding effect on receivables from customers and rebates receivables, inventories, prepaid expenses and other current assets and trade payables. Our short-term debt also fluctuates during the year to meet working capital needs. Our cash collections generally occur after the application season is complete, while customer prepayments made to us are typically concentrated in December and January and inventory prepayments paid to our vendors are typically concentrated in the period from November to January. Feed and industrial sales are more evenly distributed throughout the year.
NOTE 12 RELATED PARTY TRANSACTIONS
We sell potash from our Canadian mines for use outside Canada and the United States exclusively to Canpotex. Canpotex sells potash to buyers in export markets pursuant to term and spot contracts at agreed upon prices. Our revenue is recognized at the amount received from Canpotex representing proceeds from their sale of potash, less net costs of Canpotex. Sales to Canpotex are shown in Note 2.
As at | September 30, 2020 | December 31 ,2019 | ||||||
Receivables from Canpotex | 201 | 194 |
36